Preclinical studies indicate that INFLATIV, an herbal medicine cream containing Pereskia aculeata, presents potential to be marketed as a topical anti ‐inflammatory agent and as adjuvant in psoriasis therapy
ConclusionsThe results demonstrated the relevant therapeutic and marketing potentials of INFLATIV, which is likely to be further evaluated in clinical trials for drug registration process with regulatory agencies.
Source: Journal of Pharmacy and Pharmacology - Category: Drugs & Pharmacology Authors: N ícolas de Castro Campos Pinto,
Mariana de Souza Ferreira Maciel,
Nathalia dos Santos Rezende,
Ana Paula do Nascimento Duque,
Renata de Freitas Mendes,
Jucélia Barbosa Silva,
Monique de Rezende Evangelista,
Luana Cahon Monteiro,
Josiane Mello S Tags: Research Paper Source Type: research
More News: Clinical Trials | Complementary Medicine | Dexamethasone | Drugs & Pharmacology | Herbs | Men | Psoriasis | Skin | Study